1887
Volume 2015, Issue 2
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

The exacerbation of chronic obstructive pulmonary disease (COPD) is a major factor for the high mortality associated with the disease. There is a paucity in the lung-specific biomarkers which diagnose these exacerbations. Surfactant protein D (SP-D) is a promising biomarker in predicting clinical outcomes for patients with COPD, is lung-specific and can be detected in serum. However, the profile in which serum concentrations of SP-D change during acute exacerbation is still unclear. This study aims to estimate and compare the concentrations of serum SP-D in patients with stable disease and during the exacerbation. A cross-sectional study was conducted which composed of apparently healthy individuals (n = 28), which included 14 smokers and 14 nonsmokers, patients with stable COPD (n = 28), and patients experiencing acute exacerbations (n = 28). Pulmonary functions were performed for all groups. Serum SP-D concentrations were measured using enzyme-linked immunosorbent assay (ELISA). These concentrations were compared by analysis of variance. Serum SP-D levels were significantly elevated in patients with acute exacerbations (508.733 ± 102.813 ng/ml) compared to patients with stable COPD (337.916 ± 86.265 ng/ml) and healthy subjects (177.313 ± 46.998 ng/ml; p <  0.001). Serum SP-D levels correlated inversely with lung function parameters including FEV1%pred, FVC%pred and FEV1/FVC. Serum SP-D levels are raised early on during acute exacerbations of COPD, which could be a potential early diagnostic biomarker for COPD exacerbations.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2015.18
2016-01-26
2019-10-21
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2015/2/qmj.2015.18.html?itemId=/content/journals/10.5339/qmj.2015.18&mimeType=html&fmt=ahah

References

  1. [1]. Barnes   PJ., , Celli   BR. . Systemic manifestations and comorbidities of COPD. . Eur Respir J . 2009; ;33: 5 : 1165– 1185 .
    [Google Scholar]
  2. [2]. Wei   L., , Xu   D., , Qian   Y., , Huang   G., , Ma   W., , Liu   F., , Shen   Y., , Wang   Z., , Li   L., , Zhang   S., , Chen   Y. . Comprehensive analysis of gene-expression profile in chronic obstructive pulmonary disease. . Int J Chron Obstruct Pulmon Dis . 2015; ;10: : 1103– 1109 .
    [Google Scholar]
  3. [3]. Global Initiative for Chronic Obstructive Lung Disease . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease updated 2015. . Available at: www.goldcopd.com .
  4. [4]. Bahadori   K., , FitzGerald   JM. . Risk factors of hospitalization and readmission of patients with COPD exacerbation - systematic review. . Int J Chron Obstruct Pulmon Dis . 2007; ;2: 3 : 241– 251 .
    [Google Scholar]
  5. [5]. Thomsen   M., , Ingebrigtsen   TS., , Marott   JL., , Dahl   M., , Lange   P., , Vestbo   J., , Nordestgaard   BG. . Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. . JAMA . 2013; ;309: 22 : 2353– 2361 .
    [Google Scholar]
  6. [6]. Dickens   JA., , Miller   BE., , Edwards   LD., , Silverman   EK., , Lomas   DA., , Tal-Singer   R., , Evaluation of COPD Longitudinally to Identify Surrogate Endpoints (ECLIPSE) study investigators. . COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. . Respir Res . 2011; ;12: : 146– 155 .
    [Google Scholar]
  7. [7]. Mannino   DM. , Biomarkers in COPD: The Search Continues! Eur Respir J . 2015; ;45: 4 : 872– 874 .
    [Google Scholar]
  8. [8]. Sin   DD., , Leung   R., , Gan   WQ., , Man   SP. . Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: A pilot study. . BMC Pulm Med . 2007; ;7: : 13 .
    [Google Scholar]
  9. [9]. Bowler   RP. . Surfactant protein D as a biomarker for chronic obstructive pulmonary disease. . COPD . 2012; ;9: 6 : 651– 653 .
    [Google Scholar]
  10. [10]. Moreno   D., , Garcia   A., , Lema   D., , De Sanctis   JB. . Surfactant protein D in chornic obstructive pulmonary disease (COPD). . Recent Pat Endocr Metab Immune Drug Discov . 2014; ;8: 1 : 42– 47 .
    [Google Scholar]
  11. [11]. Sin   DD., , Pahlavan   PS., , Man   SF. . Surfactant protein D: A lung specific biomarker in COPD?.   Ther Adv Respir Dis . 2008; ;2: 2 : 65– 74 .
    [Google Scholar]
  12. [12]. Winkler   C., , Atochina-Vasserman   EN., , Holz   O., , Beers   MF., , Erpenbeck   VJ., , Krug   N., , Roepcke   S., , Lauer   G., , Elmlinger   M., , Hohlfeld   JM. . Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD. . Respir Res . 2011; ;12: 1 : 29– 39 .
    [Google Scholar]
  13. [13]. Barrow   AD., , Palarasah   Y., , Bugatti   M., , Holehouse   AS., , Byers   DE., , Holtzman   MJ., , Vermi   W., , Skjødt   K., , Crouch   E., , Colonna   M. . OSCAR is a receptor for surfactant protein D that activates TNF-α release from human CCR2+ inflammatory monocytes. . J Immunol . 2015; ;194: 7 : 3317– 3326 .
    [Google Scholar]
  14. [14]. Sorensen   GL., , Hoegh   SV., , Leth-Larsen   R., , Thomsen   TH., , Floridon   C., , Smith   K., , Kejling   K., , Tornoe   I., , Crouch   EC., , Holmskov   U. . Multimeric and trimeric subunit SP-D are interconvertible structures with distinct ligand interaction. . Mol Immunol . 2009; ;46: 15 : 3060– 3069 .
    [Google Scholar]
  15. [15]. Ju   CR., , Liu   W., , Chen   RC. . Serum surfactant protein D: Biomarker of chronic obstructive pulmonary disease. . Dis Markers . 2012; ;32: 5 : 281– 287 .
    [Google Scholar]
  16. [16]. Jaw   JE., , Sin   DD. . Unifying thoracic biomarkers: Surfactant protein-D and beyond. . Expert Rev Respir Med . 2012; ;6: 2 : 147– 154 .
    [Google Scholar]
  17. [17]. Lock-Johansson   S., , Vestbo   J., , Sorensen   G. . Surfactant protein D, club cell protein 16, pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease. . Respir Res . 2014; ;15: 1 : 147– 156 .
    [Google Scholar]
  18. [18]. Calverley   PMA., , Georgopoulos   D. . Chronic obstructive pulmonary disease: Symptoms and signs. In: Postmas S, Siafakas NM, eds. Management of chronic obstructive pulmonary disease. . Eur Respir Mon . 1998; ;8: : 6– 24 .
    [Google Scholar]
  19. [19]. Sutherland   ER., , Cherniack   RM. . Management of chronic obstructive pulmonary disease. . N Engl J Med . 2004; ;350: : 2689– 2697 .
    [Google Scholar]
  20. [20]. Shakoori   TA., , Sin   DD., , Ghafoor   F., , Bashir   S., , Bokhari   SN. . Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease. . Dis Markers . 2009; ;27: 6 : 287– 294 .
    [Google Scholar]
  21. [21]. Lomas   DA., , Silverman   EK., , Edwards   LD., , Locantore   NW., , Miller   BE., , Horstman   DH., , Tal-Singer   R., , Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints study investigators. . Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. . Eur Respir J . 2009; ;34: 1 : 95– 102 .
    [Google Scholar]
  22. [22]. Dahl   M. . Biomarkers for chronic obstructive pulmonary disease: Surfactant protein D and C-reactive protein. . Am J Respir Crit Care Med . 2008; ;177: 11 : 1177– 1178 .
    [Google Scholar]
  23. [23]. Sorensen   GL., , Husby   S., , Holmskov   U. . Surfactant protein A and surfactant protein D variation in pulmonary disease. . Immunobiology . 2007; ;212: 4–5 : 381– 416 .
    [Google Scholar]
  24. [24]. El-Deek   SE., , Makhlouf   HA., , Saleem   TH., , Mandour   MA., , Mohamed   NA. . Surfactant protein D, soluble intercellular adhesion molecule-1 and high-sensitivity C-reactive protein as biomarkers of chronic obstructive pulmonary disease. . Med Princ Pract . 2013; ;22: 5 : 469– 474 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2015.18
Loading
/content/journals/10.5339/qmj.2015.18
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error